These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 18786007)

  • 21. Functional property of von Willebrand factor under flowing blood.
    Sugimoto M; Miyata S
    Int J Hematol; 2002 Jan; 75(1):19-24. PubMed ID: 11843285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding.
    Cheng H; Yan R; Li S; Yuan Y; Liu J; Ruan C; Dai K
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2128-35. PubMed ID: 19820200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
    Ju L; Dong JF; Cruz MA; Zhu C
    J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?
    Jung SM; Sonoda M; Tsuji K; Jimi A; Nomura S; Kanaji T; Moroi M
    Platelets; 2010; 21(2):101-11. PubMed ID: 20063990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
    Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
    Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VWF attributes--impact on thrombus formation.
    Reininger AJ
    Thromb Res; 2008; 122 Suppl 4():S9-13. PubMed ID: 18929523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the von Willebrand factor with platelets and thrombosis.
    Perutelli P; Mori PG
    Recenti Prog Med; 1997 Nov; 88(11):526-9. PubMed ID: 9401429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
    Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
    J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibα Measured by Atomic Force Microscopy.
    Tobimatsu H; Nishibuchi Y; Sudo R; Goto S; Tanishita K
    J Atheroscler Thromb; 2015; 22(10):1091-9. PubMed ID: 25972025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPIb potentiates GPVI-induced responses in human platelets.
    Baker J; Griggs RK; Falati S; Poole AW
    Platelets; 2004 Jun; 15(4):207-14. PubMed ID: 15203711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A biophysical view on von Willebrand factor activation.
    Löf A; Müller JP; Brehm MA
    J Cell Physiol; 2018 Feb; 233(2):799-810. PubMed ID: 28256724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet von Willebrand factor.
    Gralnick HR; Williams SB; McKeown LP; Magruder L; Hansmann K; Vail M; Parker RI
    Mayo Clin Proc; 1991 Jun; 66(6):634-40. PubMed ID: 2046403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
    Perutelli P; Molinari AC
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
    Hrdinova J; Fernández DI; Ercig B; Tullemans BME; Suylen DPL; Agten SM; Jurk K; Hackeng TM; Vanhoorelbeke K; Voorberg J; Reutelingsperger CPM; Wichapong K; Heemskerk JWM; Nicolaes GAF
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of fluid shear stress in regulating VWF structure, function and related blood disorders.
    Gogia S; Neelamegham S
    Biorheology; 2015; 52(5-6):319-35. PubMed ID: 26600266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.
    Machha VR; Tischer A; Moon-Tasson L; Auton M
    J Mol Biol; 2017 Jan; 429(1):32-47. PubMed ID: 27889474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet adhesion to collagen.
    Nuyttens BP; Thijs T; Deckmyn H; Broos K
    Thromb Res; 2011 Jan; 127 Suppl 2():S26-9. PubMed ID: 21193111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
    Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
    Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.